Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days

Prolonged treatment with linezolid (LZD) is known to cause thrombocytopenia. However, some patients do not develop thrombocytopenia despite long-term administration of LZD. To determine the risk factors for LZD-associated thrombocytopenia in patients undergoing long-term LZD therapy, we conducted a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nagoya J Med Sci
Main Authors: Sato, Yoshitaka, Iguchi, Mitsutaka, Kato, Yoshiaki, Morioka, Hiroshi, Hirabayashi, Aki, Tetsuka, Nobuyuki, Tomita, Yuka, Kato, Daizo, Yamada, Kiyofumi, Kimura, Hiroshi, Yagi, Tetsuya
Formato: Artigo
Idioma:Inglês
Publicado em: Nagoya University 2020
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548242/
https://ncbi.nlm.nih.gov/pubmed/33132425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18999/nagjms.82.3.407
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados